My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Various WA Local Governments 9/21/2022
>
Contracts
>
Agreement
>
Interlocal Agreements
>
Various WA Local Governments 9/21/2022
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
2/26/2024 7:10:18 AM
Creation date
9/30/2022 2:40:54 PM
Metadata
Fields
Template:
Contracts
Contractor's Name
Various WA Local Governments
Approval Date
9/21/2022
Council Approval Date
9/14/2022
Department
Legal
Department Project Manager
Ramsey Ramerman
Subject / Project Title
Settlement Agreement Opioid Distributors
Tracking Number
0003472
Total Compensation
$0.00
Contract Type
Agreement
Contract Subtype
Interlocal Agreements
Retention Period
6 Years Then Destroy
Imported from EPIC
No
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
149
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Government Fee Fund("GFF") shall be established that ensures that all Parties <br /> that receive Opioid Funds contribute to the payment of fees and expenses incurred <br /> to prosecute the claims against the Pharmaceutical Supply Chain Participants, <br /> regardless of whether they are litigating or non-litigating entities. <br /> 2. The amount of the GFF shall be based as follows: the funds to be <br /> deposited in the GFF shall be equal to 15%of the total cash value of the Opioid <br /> Funds. <br /> 3. The maximum percentage of any contingency fee agreement <br /> permitted for compensation shall be 15% of the portion of the Opioid Funds <br /> allocated to the Litigating Local Government that is a party to the contingency fee <br /> agreement, plus expenses attributable to that Litigating Local Government. Under <br /> no circumstances may counsel collect more for its work on behalf of a Litigating <br /> Local Government than it would under its contingency agreement with that <br /> Litigating Local Government. <br /> 4. Payments from the GFF shall be overseen by a committee (the <br /> "Opioid Fee and Expense Committee") consisting of one representative of the <br /> following law firms: (a)Keller Rohrback L.LP.; (b) Hagens Berman Sobol <br /> Shapiro LLP; (c) Goldfarb& Huck Roth Riojas, PLLC; and (d)Napoli Shkolnik <br /> PLLC. The role of the Opioid Fee and Expense Committee shall be limited to <br /> ensuring that the GFF is administered in accordance with this Section. <br /> 5. In the event that settling Pharmaceutical Supply Chain Participants <br /> do not pay the fees and expenses of the Participating Local Governments directly <br /> at the time settlement is achieved, payments to counsel for Participating Local <br /> Governments shall be made from the GFF over not more than three years,with <br /> 50%paid within 12 months of the date of Settlement and 25%paid in each <br /> subsequent year, or at the time the total Settlement amount is paid to the Trustee <br /> by the Defendants, whichever is sooner. <br /> 6. Any funds remaining in the GFF in excess of: (i)the amounts <br /> needed to cover Litigating Local Governments' private counsel's representation <br /> agreements, and (ii)the amounts needed to cover the common benefit tax <br /> discussed in Section C.8 below (if not paid directly by the Defendants in <br /> connection with future settlement(s), shall revert to the Participating Local <br /> Governments pro rata according to the percentages set forth in Exhibits B,to be <br /> used for Approved Purposes as set forth herein and in Exhibit A. <br /> 7. In the event that funds in the GFF are not sufficient to pay all fees <br /> and expenses owed under this Section, payments to counsel for all Litigating <br /> Local Governments shall be reduced on a pro rata basis. The Litigating Local <br /> Governments will not be responsible for any of these reduced amounts. <br /> 9 <br />
The URL can be used to link to this page
Your browser does not support the video tag.